Heat shock proteins as molecular targets for intervention in atrial fibrillation

Cardiovascular Research

Volumn 78, Issue 3, 2008, Pages 422-428

  Brundel, Bianca J J M ^a   Ke, Lei ^a   Dijkhuis, Anne Jan ^a   Qi, XiaoYan ^b   Shiroshita Takeshita, Akiko ^b,c   Nattel, Stanley ^b   Henning, Robert H ^a   Kampinga, Harm H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MONTREAL HEART INSTITUTE   (Canada)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Geranylgeranylacetone; Heat shock proteins; HL 1; Hsp27; HspB1

Indexed keywords

ATORVASTATIN; BIMOCLOMOL; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLOSPORIN A; DEXAMETHASONE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN A1A; HEAT SHOCK PROTEIN B1; HEAT SHOCK PROTEIN B5; HEAT SHOCK PROTEIN B6; HEAT SHOCK PROTEIN CA; HEAT SHOCK PROTEIN D1; HEAT SHOCK PROTEIN E1; HYDROXYLAMINE; PROTEIN DNAJ; TEPRENONE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CARDIOVERSION; CELL STRESS; CELL SURVIVAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG TARGETING; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RHYTHM; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MYOCARDIAL HIBERNATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW;

EID: 44449129883     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn060     Document Type: Review

References (95)

1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-226.
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
3. Van Gelder IC, Crijns HJGM, Tieleman RG, De Kam PJ, Gosseling ATM, Verheugt FWA et al. Value and limitation of electrical cardioversion in patients with chronic atrial fibrillation-importance of arrhythmia risk factors and oral anticoagulation. Arch Intern Med 1996;156:2585-2592.
4. Todd DM, Fynn SP, Walden AP, Hobbs WJ, Arya S, Garratt CJ. Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Circulation 2004;109:1434-1439.
5. Sun H, Gaspo R, Leblanc N, Nattel S. Cellular mechanism of atrial contractile dysfuntion caused by sustained atrial tachycardia. Circulation 1998;98:719-727.
6. Yue L, Melnyk P, Gaspo Wang Z, Nattel S. Molecular mehanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999;84:776-784.
7. Qi XY, Yeh Y, Xiao L, Nattel S. Molecular mechanisms of tachycardia-dependent atrial remodeling probed in a novel in vitro model. Circulation 2006;114(Suppl. II):II-292.
8. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004;110:2651-2657.
9. Greiser M, Halaszovich CR, Frechen D, Boknik KP, Ravens U, Dobrev D et al. Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2007;375:383-392.
10. 2+ handling in human chronic atrial fibrillation. Circulation 2006;114:670-680.
11. Vest JA, Wehrens XHT, Reiken SR, Lehnart SE, Dobrev D, Chandra P et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111:2025-2032.
12. Brundel BJJM, Ausma J, Van Gelder IC, Van der Want JJL, Van Gilst WH, Crijns HJGM et al. Activation of Proteolysis by Calpains and Structural Changes in Human Paroxysmal and Persistent Atrial Fibrillation. Cardiovasc Res 2002;54:380-389.
13. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
14. Sherman AJ, Klocke FJ, Decker RS, Decker ML, Kozlowski KA, Harris KR et al. Myofibrillar disruption in hypocontractile myocardium showing perfusion-contraction matches and mismatches. Am J Physiol Heart Circ Physiol 2000;278:1320-1334.
15. Vanoverschelde JLJ, Wijns W, Depré C, Essamri B, Heyndricks S, Borgers M et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study on non-infarcted collateral dependent myocardium. Circulation 1993;87:1513-1523.
16. Bito V, Heinzel FR, Weidemann F, Dommke C, Van der Velden J, Verbeken E et al. Cellular mechanisms of contractile dysfunction in hibernating myocardium. Circ Res 2004;94:794-801.
17. Brundel BJJM, Kampinga HH, Henning RH. Calpain Inhibition Prevents Pacing induced Cellular Remodeling in a HL-1 Myocyte Model for Atrial Fibrillation. Cardiovasc Res 2004;62:521-528.
18. Leist M, Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001;2:589-598.
19. 2+ channels localized in the carboxyl terminus of the 1C subunit. J Physiol 2000;529:119-130.
20. Belles B, Hescheler J, Trautwein W, Blomgren K, Karlsson JO. A possible physiological role of the Ca-dependent protease calpain and its inhibitor calpastatin on the Ca current in guinea pig myocytes. Pflugers Arch 1988;412:554-556.
21. Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe D et al. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci USA 2002;99:11860-11865.
22. Communal C, Sumandea M, De Tombe P, Narula J, Solaro RJ, Hajjar RJ. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 2002;99:6252-6256.
23. Zhang Z, Biesiadecki BJ, Jin JP. Selective deletion of the NH2-terminal variable region of cardiac troponin T in ischemia reperfusion by myofibril-associated mu-calpain cleavage. Biochemistry 2006;45:11681-11694.
24. Sõti C, Nagy E, Giricz Z, Vigh L, Csermely P, Ferdinandy P. Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 2005;146:769-780.
25. Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 1998;83:117-132.
26. Haslbeck M, Franzmann T, Weinfurtner D, Buchner J. Some like it hot: the structure and function of small heat-shock proteins. Nat Struct Mol Biol 2005;12:842-846.
27. Kim HJ, Hwang NR, Lee KJ. Heat shock responses for understanding diseases of protein denaturation. Mol Cells 2007;23:123-131.
28. Basha E, Lee GJ, Breci LA, Hausrath AC, Buan NR, Giese KC et al. The identity of proteins associated with a small heat shock protein during heat stress in vivo indicates that these chaperones protect a wide range of cellular functions. J Biol Chem 2004;279:7566-7575.
29. Jakob U, Gaestel M, Engel K, Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem 1993;268:1517-1520.
30. Lavoie JN, Lambert H, Hickey E, Weber LA, Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 1995;15:505-516.
31. Bryantsev AL, Loktionova SA, Ilyinskaya OP, Tararak EM, Kampinga HH, Kabakow AE. Distribution, phosphorylation, and activities of Hsp25 in heat-stressed H9c2 myoblasts: a functional link to cytoprotection. Cell Stress Chaperones 2002;7:146-155.
32. Decker RS, Decker ML, Nakamura S, Zhao YS, Hedjbeli S, Harris KE et al. Hsc73-tubulin complex formation during low-flow ischemia in canine myocardium. Am J Physiol Heart Circ Physiol 2002;283:H1322-H1333.
33. Brundel BJJM, Henning RH, Ke L, Van Gelder IC, Crijns HJGM, Kampinga HH. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation. J Mol Cell Cardiol 2006;41:555-562.
34. Schafler AE, Kirmanoglou K, Balbach J, Pecher P, Hannekum A, Schumacher B. The expression of heat shock protein 60 in myocardium of patients with chronic atrial fibrillation. Basic Res Cardiol 2002;97:258-261.
35. Yang M, Tan H, Cheng L, He M, Wie Q, Tanguay RM et al. Expression of heat shock proteins in myocardium of patients with atrial fibrillation. Cell Stress Chaperones 2007;12:142-150.
36. Kampinga HH, Henning RH, Van Gelder IC, Brundel BJJM. Beat shock proteins and atrial fibrillation. Cell Stress Chaperones 2007;12:97-100.
37. Kirmanoglou K, Hannekum A, Schafler AE. Expression of mortalin in patients with chronic atrial fibrillation. Basic Res Cardiol 2004;99:404-408.
38. Lin KM, Lin B, Lian IY, Mestril R, Scheffler IE, Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001;103:1787-1792.
39. St Rammos K, Koullias GJ, Hassan MO, Argyrakis NP, Voucharas CG, Scarupa SJ et al. Low preoperative HSP70 atrial myocardial levels correlate significantly with high incidence of postoperative atrial fibrillation after cardiac surgery. Cardiovasc Surg 2002;10:228-232.
40. Mandal K, Torsney E, Poloniecki J, Camm AJ, Xu Q, Jahangiri M. Association of high intracellular, but not serum, heat shock protein 70 with postoperative atrial fibrillation. Ann Thorac Surg 2005;79:865- 871.
41. Oc M, Ucar HI, Pinar A, Akbulut B, Oc B, Akinci SB et al. Heat shock protein 60 antibody. A new marker for subsequent atrial fibrillation development. Saudi Med J 2007;28:844-847.
42. Lin L, Kim SC, Wang Y, Gupta S, Davis B, Simon SI et al. HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 2007;293:H2238-H2247.
43. Kirchhoff SR, Gupta S, Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 2002;105:2899-2904.
44. Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 2007;292:H3052-H3056.
45. Brundel BJJM, Shiroshita-Takeshita A, Qi XY, Yeh YH, Van Gelder IC, Henning RH et al. Induction of heat-shock response protects the heart against atrial fibrillation. Circ Res 2006;99:1394-1402.
46. Wakisaka O, Takahashi N, Shinohara T, Ooie T, Nakagawa M, Yonemochi H et al. Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72. J Mol Cell Cardiol 2007;43:616-626.
47. Somara S, Bitar KN. Tropomyosin interacts with phosphorylated Hsp27 in agonist-induced contraction of smooth muscle. Am J Physiol Cell Physiol 2004;286:C1290-C1301.
48. Venkatakrishnan CD, Tewari AK, Moldovan L, Cardounel AJ, Zweier JL, Kuppusamy P et al. Heat shock protects cardiac cells from Doxorubicin-induced toxicity by activating p38MAPK and phosphorylation of small heat shock protein 27. Am J Physiol Heart Circ Physiol 2006;291:H2680-H2691.
49. Leach RN, Desai JC, Orchard CH. Effect of cytoskeleton disruptors on L-type Ca channel distribution in rat ventricular myocytes. Cell Calcium 2005;38:515-526.
50. Armstead WM, Hecker JG. Heat shock protein modulation of KATP and KCa channel cerebrovasodilation after brain injury. Am J Physiol Heart Circ Physiol 2005;289:H1184-H1190.
51. Ficker E, Dennis AT, Wang L, Brown AM. Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res 2003;92:e87-e100.
52. 2+ channel. Cell Physiol Biochem 2006;17:97-110.
53. Kashlan OB, Mueller GM, Qamar MZ, Poland PA, Ahner A, Rubenstein RC et al. Small heat shock protein αA-crystallin regulates epithelial sodium channel expression. J Biol Chem 2007;282:28149-28156.
54. Patil SB, Pawar MD, Bitar KN. Phosphorylated HSP27 essential for acetylcholine-induced association of RhoA with PKCalpha. Am J Physiol Gastrointest Liver Physiol 2004;286:G635-G644.
55. Patil SB, Pawar MD, Bitar KN. Direct association and translocation of PKC-α with calponin. Am J Pysiol Gastrointest Liver Physiol 2004;286:G954-G963.
56. Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 1992;313:307-313.
57. Harnett KM, Biancani P. Calcium-dependent and calcium-independent contractions in smooth muscles. Am J Med 2003;115:24S-30S.
58. Park KJ, Gaynor RB, Kwak YT. Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation. J Biol Chem 2003;278:35272-35278.
59. Kammanadiminti SJ, Chadee K. Suppression of NF-kB activation by entamoeba histolytica in intestinal epithelial cells is mediated by heat shock protein 27. J Biol Chem 2006;281:26112-26120.
60. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003;60:315-325.
61. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z et al. Effects of Angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608-2614.
62. Voss OH, Batra S, Kolattukudy SJ, Gonzalez-Mejia ME, Smith JB, Doseff AI. Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem 2007;282:25088-25099.
63. Vigh L, Literati PN, Horvath I, Torok Z, Balogh O, Glatz A et al. Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med 1997;3:1150-1154.
64. Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, Brunstock G, Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 2004;10:402-405.
65. Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, Jamanaka K et al. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 renders protection against ischemia/reperfusion injury in rat heart. Circulation 2001;104:1837-1843.
66. Katsuno M, Sang C, Adachi H, Minamiyama M, Waza M, Tanaka F et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci USA 2005;102:16801-16806.
67. Nattel S, Carlsson L. Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 2006;5:1034-1049.
68. Shinagawa K, Derakhchan K, Nattel S. Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy. Pacing Clin Electrophysiol 2003;26:752-764.
69. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 1999;100:2191-2197.
70. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003;107:1440-1446.
71. Shiroshita-Takeshita A, Brundel BJJM, Lavoie J, Nattel S. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 2006;69:865-875.
72. Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 2004;110:2313- 2319.
73. Dernellis J, Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004;25:1100-1107.
74. Ozaydin M, Varol E, Aslan SM, Kucuktepe Z, Dogan A, Ozturk M et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol 2006;97:1490-1493.
75. Nègre-Aminou P, Van Leeuwen RE, Van Thiel GC, Van den IJssel P, De Jong WW, Quinlan RA et al. Differential effect of simvastatin on activation of Rac(1) vs activation of the heat shock protein 27-mediated pathway upon oxidative stress, in human smooth muscle cells. Biochem Pharmacol 2002;64:1483-1491.
76. Son GH, Geum D, Chung S, Park E, Lee KH, Choi S et al. A protective role of 27-kDa heat shock protein in glucocorticoid-evoked apoptotic cell death of hippocampal progenitor cells. Biochem Biophys Res Commun 2005;338:1751-1758.
77. Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996;111:345-357.
78. Yamanaka K, Takahashi N, Ooie T, Kaneda K, Yoshimatsu H, Saikawa T. Role of protein kinase C in geranylgeranylacetone-induced expression of heat-shock protein 72 and cardioprotection in the rat heart. J Mol Cell Cardiol 2003;35:785-794.
79. Yamagami K, Yamamoto Y, Ishikawa Y, Yonezawa K, Toyokuni S, Yamaoka Y. Effects of geranyl-geranyl-acetone administration before heat shock preconditioning for conferring tolerance against ischemia-reperfusion injury in rat livers. J Lab Clin Med 2000;135:465-475.
80. Shiroshita-Takeshita A, Sakabe M, Maguy A, Cardin S, Brundel BJJM, Nattel S. Heat shock protein induction attenuates atrial remodeling and atrial fibrillation promotion in dogs with ventricular tachycardiomyopathy. 2007, submitted for publication.
81. Sakabe M, Shiroshita-Takeshita A, Maguy A, Brundel BJJM, Fujiki A, Inoue H et al. Effects of heat shock protein induction on Atrial Fibrillation caused by acute atrial ischemia. Cardiovasc Res 2008;78:63-70.
82. Plumier JC, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G et al. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 1995;95:1854-1860.
83. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmaann WH. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 1995;95:1446-1456.
84. Hayashi M, Imanaka-Yoshida K, Yoshida T, Wood M, Frearns C, Tatake RJ et al. A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy. Nature Med 2006;1:128-132.
85. Kwon JH, Kim JB, Lee KH, Kang SM, Chung N, Jang Y et al. Protective effect of heat shock protein 27 using protein transduction domain-mediated delivery on ischemia/reperfusion heart injury. Biochem Biophys Res Commun 2007;363:399-404.
86. Efthymiou CA, Mocanu MM, de Belleroche J, Wells DJ, Latchmann DS, Yellon DM. Heat shock protein 27 protects the heart against myocardial infarction. Basic Res Cardiol 2004;99:392-394.
87. Rajasekaran NS, Connell P, Christians ES, Yan LJ, Taylor RP, Orosz A et al. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 2007;130:427- 439.
88. Inagaki N, Hayashi T, Arimura T, Koga Y, Takahashi M, Shibata H et al. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun 2006;342:379-386.
89. Fan GC, Yuan Q, Song G, Wang Y, Chen G, Qian J et al. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. Circ Res 2006;99:1233-1242.
90. Kupatt C, Dessy C, Hinkel R, Raake P, Daneau G, Bouzin C et al. Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation. Arterioscler Thromb Vasc Biol 2004;24:1435-1441.
91. Shinohara T, Takahashi N, Kohno H, Yamanaka U, Ooie T, Wakisaka O et al. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart. Am J Physiol Heart Circ Physiol 2007;293:H1892-H1899.
92. Sun L, Chang J, Kirchhoff SR, Knowlton AA. Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment. Am J Physiol Heart Circ Physiol 2000;278:H1091-H1097.
93. Efthymiou CA, Mocanu MM, Yellon DM. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling. J Cardiovasc Pharmacol 2005;45:247-252.
94. Lubbers NL, Polakowski JS, Wegner CD, Burke SE, Diaz GJ, Daniell KM et al. Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats. Eur J Pharmacol 2002;435:79-83.
95. Chen HW, Chien CT, Yu SL, Lee YT, Chen WJ. Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via ROS generation, iNOS and Hsp70. Br J Pharmacol 2002;137:771-781.